Baseline bone mineral density testing among breast cancer patients prescribed aromatase inhibitors (AIs).

被引：0
|
作者：
Charlson, John A. [1 ]
Smith, Elizabeth [1 ]
Laud, Purushottam [1 ]
Smallwood, Alicia [1 ]
Neuner, Joan [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6642
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors
    Charlson, John
    Smith, Elizabeth C.
    Smallwood, Alicia J.
    Laud, Purushottam W.
    Neuner, Joan M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (07): : 875 - 880
  • [2] EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Khachidze, N.
    Giorgadze, E.
    Tsagareli, M.
    Dolidze, N.
    Sharikadze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S237 - S238
  • [3] Impact of adjuvant aromatase inhibitors on bone mineral density in breast cancer patients
    Lai, C. N.
    Correa, P. D.
    Alhasso, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Effects of Aromatase inhibitors on bone mineral density and trabecular bone score in patients with breast cancer
    Dabbagh, V.
    Shandiz, F. Homaee
    Kermani, A. Taghizadeh
    Javan, F. Nesari
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S465 - S465
  • [5] EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY AND TRABECULAR BONE MICROARCHITECTURE IN PATIENTS WITH BREAST CANCER
    Tsagareli, M.
    Giorgadze, E.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S189 - S189
  • [6] Bone mineral density in women with breast cancer and the impact of aromatase inhibitors
    Saleh, B.
    Gronland, N.
    Singer, J.
    Bradpiece, H.
    Patel, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : 384 - 385
  • [7] COMPLIANCE OF BONE MINERAL DENSITY TESTING FOR PATIENTS WHO ARE PRESCRIBED AROMATASE INHIBITORS IN ONE PRIVATE PRACTICE.
    Servodidio, Camille
    Hong, Susanna
    Malon, Andrea
    Gould-Mitchell, Kathleen
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : 63 - 63
  • [8] Bone Mineral Density Screening Among Women with a History of Breast Cancer Treated with Aromatase Inhibitors
    Spangler, Leslie
    Yu, Onchee
    Loggers, Elizabeth
    Boudreau, Denise M.
    JOURNAL OF WOMENS HEALTH, 2013, 22 (02) : 132 - 140
  • [9] Bone mineral density screening and monitoring in early breast cancer patients treated with aromatase inhibitors
    Gilani, S.
    Ikram, N.
    ANNALS OF ONCOLOGY, 2022, 33 : S227 - S227
  • [10] Bone mineral density change on aromatase inhibitors as a predictor of breast cancer recurrence
    Martin, Hilary L.
    Davidson, John A.
    Yap, Francis
    Chung, Kim
    Khattak, Muhammad A.
    Redfern, Andrew D.
    CANCER RESEARCH, 2015, 75
12345